Seminars in Radiation Oncology
Volume 16, Issue 4 , Pages 232-238 , October 2006

Is PET-Based Treatment Planning the New Standard in Modern Radiotherapy? The Head and Neck Paradigm

  • Vincent Grégoire, MD, PhD

      Affiliations

    • Corresponding Author InformationAddress reprint requests to Vincent Grégoire, MD, PhD, Department of Radiation Oncology, St-Luc University Hospital, 10 Avenue Hippocrate, 1200 Brussels, Belgium.
    • ,
  • Anne Bol, MSc, PhD
    • ,
  • Xavier Geets, MD
    • ,
  • John Lee, Eng PhD

References 

  1. Bernier J , Hall EJ , Giaccia A . Radiation oncology: A century of achievements . Nat Rev Cancer . 2004;4:737–747
  2. Moran JM , Elshaikh MA , Lawrence TS . Radiotherapy: What can be achieved by technical improvements in dose delivery? . Lancet Oncol . 2005;6:51–58
  3. Rohren EM , Turkington TG , Coleman RE . Clinical applications of PET in oncology . Radiology . 2004;231:305–332
  4. Braams JW , Pruim J , Freling NJ , et al.   Detection of lymph node metastases of squamous-cell cancer of the head and neck with FDG-PET and MRI . J Nucl Med . 1995;36:211–216
  5. Laubenbacher C , Saumweber D , Wagner-Manslau C , et al.   Comparison of fluorine-18-fluorodeoxyglucose PET, MRI and endoscopy for staging head and neck squamous-cell carcinomas . J Nucl Med . 1995;36:1747–1757
  6. McGuirt WF , Williams DW , Keyes JW , et al.   A comparative diagnostic study of head and neck nodal metastases using positron emission tomography . Laryngoscope . 1995;105:373–375
  7. Benchaou M , Lehmann W , Slosman DO , et al.   The role of FDG-PET in the preoperative assessment of N-staging in head and neck cancer . Acta Otolaryngol . 1996;116:332–335
  8. Myers LL , Wax MK . Positron emission tomography in the evaluation of the negative neck in patients with oral cavity cancer . J Otolaryngol . 1998;27:342–347
  9. Stokkel MP , ten Broek FW , Hordijk GJ , et al.   Preoperative evaluation of patients with primary head and neck cancer using dual-head 18-fluorodeoxyglucose positron emission tomography . Ann Surg . 2000;231:229–234
  10. Stuckensen T , Kovacs AF , Adams S , et al.   Staging of the neck in patients with oral cavity squamous cell carcinomas: A prospective comparison of PET, ultrasound, CT and MRI . J Craniomaxillofac Surg . 2000;28:319–324
  11. Dammann F , Horger M , Mueller-Berg M , et al.   Rational diagnosis of squamous cell carcinoma of the head and neck region: comparative evaluation of CT, MRI, and 18FDG PET . AJR Am J Roentgenol . 2005;184:1326–1331
  12. Shah JP . Patterns of cervical lymph node metastasis from squamous carcinomas of the upper aerodigestive tract . Am J Surg . 1990;160:405–409
  13. Pieterman RM , van Putten JW , Meuzelaar JJ , et al.   Preoperative staging of non-small-cell lung cancer with positron-emission tomography . N Engl J Med . 2000;343:254–261
  14. Poncelet AJ , Lonneux M , Coche E , et al.  Groupe d’Oncologie Thoracique des Cliniques Saint-Luc   PET-FDG scan enhances but does not replace preoperative surgical staging in non-small cell lung carcinoma . Eur J Cardiothorac Surg . 2001;20:468–474
  15. Kernstine KH , Mclaughlin KA , Menda Y , et al.   Can FDG-PET reduce the need for mediastinoscopy in potentially resectable nonsmall cell lung cancer? . Ann Thorac Surg . 2002;73:394–401
  16. Gould MK , Kuschner WG , Rydzak CE , et al.   Test performance of positron emission tomography and computed tomography for mediastinal staging in patients with non-small-cell lung cancer: A meta-analysis . Ann Intern Med . 2003;139:879–892
  17. Schrevens L , Lorent N , Dooms C , et al.   The role of PET scan in diagnosis, staging, and management of non-small cell lung cancer . Oncologist . 2004;9:633–643
  18. van Westreenen HL , Westerterp M , Bossuyt PM , et al.   Systematic review of the staging performance of 18F-fluorodeoxyglucose positron emission tomography in esophageal cancer . J Clin Oncol . 2004;22:3805–3812
  19. Vrieze O , Haustermans K , De Wever W , et al.   Is there a role of FDG-PET in radiotherapy planning in esophageal carcinoma? . Radiother Oncol . 2004;73:269–275
  20. Reinhardt MJ , Ehritt-Braun C , Vogelgesang D , et al.   Metastatic lymph nodes in patients with cervical cancer: Detection with MR imaging and FDG PET . Radiology . 2001;218:776–782
  21. Rose PG , Adler LP , Rodriguez M , et al.   Positron emission tomography for evaluating para-aortic nodal metastasis in locally advanced cervical cancer before surgical staging: A surgicopathologic study . J Clin Oncol . 1999;17:41–45
  22. Sugawara Y , Eisbruch A , Kosuda S , et al.   Evaluation of FDG PET in patients with cervical cancer . J Nucl Med . 1999;40:1125–1131
  23. Antoch G , Saoudi N , Kuehl H , et al.   Accuracy of whole-body dual-modality fluorine-18-2-fluoro-2-deoxy-D-glucose positron emission tomography and computed tomography (FDG-PET/CT) for tumor staging in solid tumors: comparison with CT and PET . J Clin Oncol . 2004;22:4357–4368
  24. Bar-Shalom R , Yefremov N , Guralnik L , et al.   Clinical performance of PET/CT in evaluation of cancer: Additional value for diagnostic imaging and patient management . J Nucl Med . 2003;44:1200–1209
  25. Yeung HW , Schoder H , Smith A , et al.   Clinical value of combined positron emission tomography/computed tomography imaging in the interpretation of 2-deoxy-2-[F-18]fluoro-D-glucose-positron emission tomography studies in cancer patients . Mol Imaging Biol . 2005;7:229–235
  26. Ciernik IF , Dizendorf E , Baumert BG , et al.   Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study . Int J Radiat Oncol Biol Phys . 2003;57:853–863
  27. Wienhard K , Dahlbom M , Eriksson L , et al.   The ECAT EXACT HR (Performance of a new high resolution positron scanner) . J Comput Assist Tomogr . 1994;18:110–118
  28. Tarantola G , Zito F , Gerundini P . PET instrumentation and reconstruction algorithms in whole-body applications . J Nucl Med . 2003;44:756–769
  29. Brix G , Zaers J , Adam L-E , et al.   Performance evaluation of a whole-body PET scanner using the NEMA protocol . J Nucl Med . 1997;38:1614–1623
  30. Alessio A , Kinahan P . PET image reconstruction . In:  Henkin R ,  Bova D ,  Dillehay GL , et al. editor. Nuclear Medicine . (ed 2).. New York, NY: Elsevier; 2006;
  31. Gonzales RC , Wood RE . Digital Image Processing . (ed 2).. Reading, MA: Addison-Wesley Publishing Company; 1992;
  32. Elad M . On the origin of the bilateral filter and ways to improve it . IEEE Trans Image Process . 2002;10:1141–1151
  33. Nagayoshi M , Murase K , Fujino K , et al.   Usefulness of noise adaptive non-linear Gaussian filter in FDG-PET study . Ann Nucl Med . 2005;19:469–477
  34. Carasso AS . Linear and nonlinear image deblurring: A documented study . SIAM J Numer Anal . 1999;36:1659–1689
  35. Nishioka T , Shiga T , Shirato H , et al.   Image fusion between 18FDG-PET and MRI/CT for radiotherapy planning of oropharyngeal and nasopharyngeal carcinomas . Int J Radiat Oncol Biol Phys . 2002;53:1051–1057
  36. Paulino AC , Koshy M , Howell R , et al.   Comparison of CT- and FDG-PET-defined gross tumor volume in intensity-modulated radiotherapy for head-and-neck cancer . Int J Radiat Oncol Biol Phys . 2005;61:1385–1392
  37. Gregoire V , Daisne JF , Geets X . Comparison of CT- and FDG-PET-defined GT: In regard to Paulino et al . (Int J Radiat Oncol Biol Phys 2005;61:1385-1392) Int J Radiat Oncol Biol Phys . 2005;63:308–309
  38. Daisne JF , Sibomana M , Bol A , et al.   Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: Influence of reconstruction algorithms . Radiother Oncol . 2003;69:247–250
  39. Daisne JF , Gregoire V , Duprez T , et al.   Tumor volume in pharyngolaryngeal squamous cell carcinoma: Comparison at CT, MR imaging, and FDG PET and validation with surgical specimen . Radiology . 2004;233:93–100
  40. Nestle U , kremp S , Kirsch CM , et al.   Comparison of different methods for delineation of 18F-FDG PET-positive tissue for target volume definition in radiotherapy of patients with non-small cell lung cancer . J Nucl Med . 2005;46:1342–1348
  41. Black QC , Grills IS , Kestin LL , et al.   Defining a radiotherapy target with positron emission tomography . Int J Radiat Oncol Biol Phys . 2004;60:1272–1282
  42. Geets X , Lee J , Lonneux M , et al.   Re-assessment of tumor volume during radiotherapy with anatomic and functional imaging in head and neck cancers . Radiother Oncol . 2006;78:S59; (suppl 1) 2006
  43. Kubota R , Kubota K , Yamada S , et al.   Microautoradiographic study for the differentiation of intratumoral macrophages, granulation tissues and cancer cells by the dynamics of fluorine-18-fluorodeoxyglucose uptake . J Nucl Med . 1994;35:104–112
  44. Anzai Y , Minoshima S , Wolf GT , et al.   Head and neck cancer: detection of recurrence with three-dimensional principal components analysis at dynamic FDG PET . Radiology . 1999;212:285–290
  45. Shields AF , Grierson JR , Dohmen BM , et al.   Imaging proliferation in vivo with [F-18]FLT and positron emission tomography . Nat Med . 1998;4:1334–1336
  46. Borbath I , Gregoire V , Bergstrom M , et al.   Use of 5-[(76)Br]bromo-2′-fluoro-2′-deoxyuridine as a ligand for tumour proliferation: Validation in an animal tumour model . Eur J Nucl Med Mol Imaging . 2002;29:19–27
  47. Gronroos T , Bentzen L , Marjamaki P , et al.   Comparison of the biodistribution of two hypoxia markers [18F]FETNIM and [18F]FMISO in an experimental mammary carcinoma . Eur J Nucl Med Mol Imaging . 2004;31:513–520
  48. Mahy P , De Bast M , Leveque PH , et al.   Preclinical validation of the hypoxia tracer 2-(2-nitroimidazol-1-yl)- N-(3,3,3-[(18)F]trifluoropropyl)acetamide, [(18)F]EF3 . Eur J Nucl Med Mol Imaging . 2004;31:1263–1272
  49. Mishani E , Abourbeh G , Jacobson O , et al.   High-affinity epidermal growth factor receptor (EGFR) irreversible inhibitors with diminished chemical reactivities as positron emission tomography (PET)-imaging agent candidates of EGFR overexpressing tumors . J Med Chem . 2005;48:5337–5348
  50. Ling CC , Humm J , Larson S , et al.   Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality . Int J Radiat Oncol Biol Phys . 2000;47:551–560
  51. Chao KS , Bosch WR , Mutic S , et al.   A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy . Int J Radiat Oncol Biol Phys . 2001;49:1171–1182
  52. De Ruysscher D , Wanders S , Minken A , et al.   Effects of radiotherapy planning with a dedicated combined PET-CT-simulator of patients with non-small cell lung cancer on dose limiting normal tissues and radiation dose-escalation: A planning study . Radiother Oncol . 2005;77:5–10
  53. Douglas JG , Stelzer KJ , Mankoff DA , et al.   [F-18]-fluorodeoxyglucose positron emission tomography for targeting radiation dose escalation for patients with glioblastoma multiforme: Clinical outcomes and patterns of failure . Int J Radiat Oncol Biol Phys . 2006;64:886–891
  54. Moureau-Zabotto L , Touboul E , Lerouge D , et al.   Impact of CT and 18F-deoxyglucose positron emission tomography image fusion for conformal radiotherapy in esophageal carcinoma . Int J Radiat Oncol Biol Phys . 2005;63:340–345
  55. Mutic S , Malyapa RS , Grigsby PW , et al.   PET-guided IMRT for cervical carcinoma with positive para-aortic lymph nodes—A dose-escalation treatment planning study . Int J Radiat Oncol Biol Phys . 2003;55:28–35
  56. Vanuytsel LJ , Vansteenkiste JF , Stroobants SG , et al.   The impact of (18)F-fluoro-2-deoxy-D-glucose positron emission tomography (FDG-PET) lymph node staging on the radiation treatment volumes in patients with non-small cell lung cancer . Radiother Oncol . 2000;55:317–324
  57. Bussink J , Kaanders JH , Rijken PF , et al.   Multiparameter analysis of vasculature, perfusion and proliferation in human tumour xenografts . Br J Cancer . 1998;77:57–64
  58. Humm JL , Lee J , O’Donoghue JA , et al.   Changes in FDG tumor uptake during and after fractionated radiation therapy in a rodent tumor xenograft . Clin Positron Imaging . 1999;2:289–296
  59. Haustermans K , Vanuytsel L , Geboes K , et al.   In vivo cell kinetic measurements in human oesophageal cancer: What can be learned from multiple biopsies? . Eur J Cancer . 1994;30A:1787–1791
  60. Geets X , Daisne JF , Tomsej M , et al.   Impact of the type of imaging modality on target volumes delineation and dose distribution in pharyngo-laryngeal squamous cell carcinoma: Comparison between pre- and per-treatment studies . Radiother Oncol . 2006;78:291–297
  61. Bentzen SM . Theragnostic imaging for radiation oncology: dose-painting by numbers . Lancet Oncol . 2005;6:112–117
  62. Alber M , Paulsen F , Eschmann SM , et al.   On biologically conformal boost dose optimization . Phys Med Biol . 2003;48:N31–N35
  63. Barker JL , Garden AS , Ang KK , et al.   Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system . Int J Radiat Oncol Biol Phys . 2004;59:960–970

PII: S1053-4296(06)00032-4

doi: 10.1016/j.semradonc.2006.04.006

Seminars in Radiation Oncology
Volume 16, Issue 4 , Pages 232-238 , October 2006

Article Tools

* Image Usage & Resolution